Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fluxergy has developed an open multimodal point-of-care diagnostic platform capable of running molecular, immunoassay, clinical chemistry, hematology, and cytometry-based tests on a single analyzer. The system enables rapid sample-to-answer workflows with results in under an hour for many applications. The company has commercialized several veterinary diagnostic panels and COVID‑19 PCR tests; human health menu expansion—including STIs/sepsis—is underway via collaborations with NIH/NIAID.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fluxergy.